[HTML][HTML] Humanistic care interventions in patients with lower extremity arteriosclerosis obliterans
Y He, C Xie, Y Xia, J Rang, L Peng - American journal of …, 2021 - ncbi.nlm.nih.gov
Objective: This study was designed to investigate the application value of humanistic care
interventions in patients with lower extremity arteriosclerosis obliterans (LEASO). Methods …
interventions in patients with lower extremity arteriosclerosis obliterans (LEASO). Methods …
Clinical significance of endothelin-1 and C reaction protein in restenosis after the intervention of lower extremity arteriosclerosis obliterans
W Lian, H Nie, Y Yuan, K Wang, W Chen… - Journal of Investigative …, 2021 - Taylor & Francis
Objective This study aims to investigate the role of endothelin-1 (ET-1) and C-reactive
protein (CRP) in restenosis after intervention of lower extremity arteriosclerosis obliterans …
protein (CRP) in restenosis after intervention of lower extremity arteriosclerosis obliterans …
Medication for acromegaly reduces expression of MUC16, MACC1 and GRHL2 in pituitary neuroendocrine tumour tissue
R Saksis, I Silamikelis, P Laksa, K Megnis… - Frontiers in …, 2021 - frontiersin.org
Acromegaly is a disease mainly caused by pituitary neuroendocrine tumor (PitNET)
overproducing growth hormone. First-line medication for this condition is the use of …
overproducing growth hormone. First-line medication for this condition is the use of …
Serum inflammatory factors such as MMP-9 are associated with post-percutaneous transluminal angioplastyacute myocardial infarction in coronary heart disease …
C Shao, B Wuren, G Chi, H Ren, F Li… - Cellular and Molecular …, 2023 - cellmolbiol.org
This clinical study mainly analyzed the correlation of changes in serum inflammatory factors
(IFs), such as matrix metalloproteinase (MMP)-9, hypersensitive C-reactive protein (hs …
(IFs), such as matrix metalloproteinase (MMP)-9, hypersensitive C-reactive protein (hs …
Analysis of characteristics of pulse-graph parameters in patients with different degree of coronary artery occlusion.
LIU Lu, Z Chunke, YAN Jianjun… - Journal of Beijing …, 2022 - search.ebscohost.com
Objective To establish a model for assessing the degree of coronary artery obstruction
based on features of their pulse-graph parameters, so as to explore the clinical diagnostic …
based on features of their pulse-graph parameters, so as to explore the clinical diagnostic …
[PDF][PDF] 跨病灶压力梯度检测在下肢动脉硬化闭塞症腔内治疗的应用价值
贺超贵, 李可, 陈克勤, 彭汉武… - Progress in Modern …, 2021 - biomed.cnjournals.com
摘要目的: 探讨跨病灶压力梯度(TLPG) 检测在下肢动脉硬化闭塞症腔内治疗中的应用价值.
方法: 选取2018 年1 月~ 2019 年6 月于长沙市第一医院住院并进行腔内治疗的73 …
方法: 选取2018 年1 月~ 2019 年6 月于长沙市第一医院住院并进行腔内治疗的73 …
[PDF][PDF] 药物涂层球囊, Viabahn 覆膜支架及金属裸支架治疗下肢动脉硬化闭塞症的效果比较
黄鑫龙, 王君松, 苏振清 - 心电与循环 - xdyxh.com
目的比较药物涂层球囊(DCB), Viabahn 覆膜支架及金属裸支架(BMS) 治疗下肢动脉硬化闭塞症
(ASO) 的效果. 方法选取2017 年7 月至2019 年12 月在温岭市第一人民医院治疗的下肢ASO …
(ASO) 的效果. 方法选取2017 年7 月至2019 年12 月在温岭市第一人民医院治疗的下肢ASO …
Identification of novel prognostic targets in coronary artery disease and related complications using bioinformatics and next generation sequencing data analysis
B Vastrad, C Vastrad - bioRxiv, 2023 - biorxiv.org
Coronary artery disease (CAD) is the most common cardiovascular disorder and the leading
cause of heart-related deaths in world. Increasing molecular targets have been discovered …
cause of heart-related deaths in world. Increasing molecular targets have been discovered …
[Retracted] Clinical Efficacy of Interventional Therapy on Lower Extremity Arteriosclerosis Obliterans and Prognostic Factors
D Xiao, J Song - Computational and Mathematical Methods in …, 2022 - Wiley Online Library
Objective. This study was designed to analyse the clinical efficacy of interventional therapy
on lower extremity arteriosclerosis obliterans (LEASO) and prognostic factors. Methods. A …
on lower extremity arteriosclerosis obliterans (LEASO) and prognostic factors. Methods. A …
Bioinformatics analysis of differentially expressed genes in non alcoholic fatty liver disease using next generation sequencing data
B Vastrad, C Vastrad - bioRxiv, 2021 - biorxiv.org
Non alcoholic fatty liver disease (NAFLD) is the most common metabolic disease in humans,
affecting the majority of individuals. In the current investigation, we aim to identify potential …
affecting the majority of individuals. In the current investigation, we aim to identify potential …